Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1993-11-17
1996-12-03
Stanton, Brian R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 931, 424 932, 435 691, 435 697, 435 711, 4351723, 4352402, 43524021, 935 62, 935 70, 935 71, 935 34, A61K 4800, A61K 3512, C12N 1563, C12N 506
Patent
active
055805582
ABSTRACT:
Disclosed are methods that achieve i) site-directed delivery, ii) in situ amplification, and iii) sustained expression of an exogenous gene product within renal glomeruli. An exogenous gene, E. coli .beta.-galactosidase, was introduced into cultured rat mesangial cells using a replication-defective retrovirus, and stable infectants were administered to a rat kidney via the renal artery. In the injected kidney, the engineered, cultured mesangial cells populated 40% of glomeruli site-specifically. The gene product was detected throughout a 14-week period of observation. In an alternative method, engineered, cultured mesangial cells were injected into a kidney subjected to an antibody that induces mesangiolysis followed by mesangial regeneration. Under these conditions, expression of .beta.-galactosidase was dramatically amplified in situ, and high level expression continued for at least 8 weeks.
REFERENCES:
Woolf et al., Kidney Int. 43 (suppl. 39): 5116-5119 (1993).
A. Remuzzi, et al., Am. J. Physiol. 263, F562-F572 (1992).
Brenner and Rector (eds.) The Kidney, vol. I, W. B. Saunders Co., Philadelphia. pp. 10-11 (1991).
M. Kashgarian and R. B. Sterzel, Kidney Int. 41:524-529 (1992).
H. Kawachi, et al., Clin. Exp. Immunol. 88, pp. 399-404 (1992).
H. Kawachi, et. al., Clin. Exp. Immunol. 90, 129-134 (1992).
W. H. Baricos and S. V. Shah, Kidney Int. 40, pp. 161-173 (1991).
J. Price, D. Turner, C. Cepko, Proc. Natl. Acad. Sci. USA 84, 156-160 (1987).
M. Kitamura, et al., Kidney Int. 40, pp. 653-661 (1991).
J. Am. Soc. Nephrol. vol. 3: p. 516 #97P (1992), Thomas et. al.
J. Am. Soc. Nephrol. vol. 3: p. 636 #52P (1992), Kitamura et al.
Grossman, M., et al., Nature Genetics 6: 335-341 (1994).
Cline, 1985. Pharmac. Ther. 29:69-86.
Chowdhury et al. 1991. Science 254:1802-1805.
Tomita et al. 1992. Nippon Rinsho. 50(12):2878 Abstract Only.
Schlondorff. 1987. FASEB J. 1:272-281.
Culture of Animal Cells: A Manual of Basic Technique; Alan R. Liss, N.Y. R. Ian Freshney, Ed. 1987. pp. 197-214.
Borecki Thomas S.
Ellinger Mark S.
Mattenson Charles R.
Stanton Brian R.
The Jikei University School of Medicine
LandOfFree
Delivery of gene products via mesangial cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery of gene products via mesangial cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery of gene products via mesangial cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-783278